The goal at the first stage of histoepigenetic analysis (see “Materials and methods” and Fig. 2a) was to group tumor samples based on cancer cell intrinsic MSLN expression—addressing complications introduced by tumor purity differences (Supplementary Fig. 1)—and to compare those with high vs. low expression. The gene discussed is MSLN; the disease is cancer.